Labcorp reaffirms 2026-2029 outlook, sees 5%-8% revenue CAGR
Bitget2026/09/22 20:44- Labcorp reaffirmed its 2026-2029 long-term outlook following CMS preliminary 2027-2029 Clinical Laboratory Fee Schedule rates under PAMA.
- Outlook targets 5%-8% compound annual revenue growth, 8.5%-11.5% compound annual adjusted EPS growth.
- Adjusted operating margin expected to expand 75-150 basis points by end-2029; free cash flow growth seen in line with adjusted earnings.
- Management expects to update on the CMS rate impact when it issues 2027 financial guidance in February 2027.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Pre-orders for GTA 6 are booming and may reverse the downward trend! Citigroup raises Take-Two Interactive Software (TTWO.US) target to $270
Citigroup maintains a "Buy" rating on Take-Two Interactive Software, with a target price of $270.
Silver Price Forecast: XAG/USD trades flat around $53 ahead of US inflation data
Swiss Franc holds ground as US Dollar consolidates ahead of CPI inflation data
Net profit surges fivefold but masks decline in core business; crypto mining companies' shift to AI poses hidden risks
Marathon Holdings' Q3 net profit reached $632 million, up 413% year-on-year. However, its mining revenue declined by 35%. The company relied on selling 13,500 BTC to pay off debts and is now betting on AI infrastructure, increasing the risk of an imbalanced profit structure.
Crypto prices
More
